Mary Kay Inc. Champions Business Excellence, Ethics and Social Responsibility in Direct Selling Sector and Beauty Industry, Reaps Rewards in Europe
On May 22, the global beauty company announced Chairman and CEO David Holl is among the top ten most reputable chief executives in the world according to Reputation Institute’s 2019 CEO RepTrak® study. Reputation Institute, the world’s leading provider of reputation intelligence, measured the reputation of more than 140 global CEOs and canvassed more than 230,000 individual ratings among the informed public. The study was conducted in January and February of this year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190710005268/en/
Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)
According to Kylie Wright-Ford, CEO at Reputation Institute, acting responsibly, behaving ethically and caring about social issues are the most important drivers of CEO reputation. In fact, according to Reputation Institute’s findings, CEOs are more likely to be judged on ethics versus profit margins. In this way, the perception of CEOs and the companies they lead are directly correlated.
This meaningful recognition echoes the series of milestones reached by Mary Kay in Europe over the past months. In 2018 and 2019, Mary Kay's Europe Region earned over 90 product and industry awards and counting — a testament to Mary Kay’s mission to enrich women’s lives, offer science-driven products women love and a long-standing commitment to give back to the community.
“In a highly competitive environment, Mary Kay’s business values stand out around the world, and shine in Europe,” said Tara Eustace, President of the Mary Kay Europe Region. “Each of these awards materialize the truth of our commitment; they also provide Independent Beauty Consultants in Europe pride to celebrate with their customers and share product news and updates, while reinforcing confidence in the brand,” added Eustace.
Recent awards include:
Excellence in Direct Selling
Seldia, the European Direct Selling Association, recently recognized Mary Kay Europe as “Best Company of the Year” at its 2018 Astra Awards. In July 2019, Mary Kay Belarus received the “Direct Sales Cosmetic Company Number One Award” from the “Number One” annual national awards. In June 2019, Mary Kay Ukraine was recognized as “Number 1
Direct Selling Cosmetic Brand” in the “Favor of Success” survey. Mary Kay Spain has been the 2014, 2015, 2016 and 2017 “Number 1 Direct Selling Cosmetic Company” according to the Commercial Register data.
Excellence in Women’s Leadership
In April 2019, Mary Kay Russia’s General Manager, Alla Sokolova, received the "Manager of the Year Award” from Russian Business Guide's People of the Year, recognizing her contribution to the development of the Russian economy and entrepreneurship in Russia.
In 2016, 2017, and 2018, Mary Kay Spain's General Manager, Gema Aznar, was featured in YoDona magazine's annual “500 Most Influential Women in Spain” list highlighted in its special edition called “Female Power.”
Excellence in Women’s Entrepreneurship and Empowerment
On May 24, the “Secrets of Big Business with Mary Kay®” program created by Mary Kay Russia was recognized as the “2019 Best Social Project of Russia Award” in the “Social Entrepreneurship” category. In November 2018, Mary Kay Russia had already earned the “Woman Who Matters Award” rewarding women’s entrepreneurship for the “Secrets of Big Business with Mary Kay®” program. “Woman Who Matters” identifies the best initiatives, practices and programs of Russian companies aimed at women’s support.
Mary Kay Russia also received the “2018 Best Social Project of Russia Award” for its “Beauty of Confidence” campaign and Skin Care Labs. The Best Russian Social Project annual contest was held in May, with more than 70 companies submitting their social projects. The program was created to support the Russian government’s plans to strengthen social policies.
Mary Kay Belarus received a “2018 Brand of the Year” Silver Medal in the Social Responsibility category for its socially active position. The award was a result of the implementation of the “Beauty That Counts” program and the company's contribution to the development of women's entrepreneurship in Belarus.
Mary Kay UK received the “Company with Heart Award” at the 2018 UK Pride of Direct Selling Awards for their partnership with the Look Good, Feel Better charity. “The Company with Heart Award” is awarded to the company which has gone the extra mile to make a charitable impact through its philanthropic activities and community engagement work.
Excellence in Digital Training
Mary Kay was recognized in the “2019 Spring Omni Awards” with a coveted gold ranking in the Educational category for its innovative Link & Learn™ sales education system. The e-learning platform hosts a robust learning curriculum designed to amplify educational support for the independent sales force and increase their business success. It also connects Mary Kay Independent Beauty Consultants to a learning community based on content, accessibility and localization. Mary Kay’s Link & Learn™
was also awarded a “2018 Technology Excellence Award” from the Brandon Hall Group last January with a Bronze Medal in the category of Best Advance in Learning Management Technology for External Training.
Excellence in Digital & Printed Tools
In April, Mary Kay Russia’s MirrorMe™ App won the "2019 Best Corporate Media Award” in the "Client Media: Web Media” category. With the Mary Kay® MirrorMe™ mobile application, anyone can create beautiful makeup without any makeup tools.
Mary Kay Russia’s “Applause” magazine for Independent Beauty Consultants won two awards in 2018: the "Media Leader Award” in the category "Best Corporate Magazine" and the “Silver Threads Award” in the category “Best Corporate Edition.”
Excellence as an Employer
Mary Kay Spain and Mary Kay Poland earned the “2018 AON Best Employers Award,” recognizing organizations demonstrating excellence in the workplace.
Product Excellence
With more than 1,500 patents and a team of scientists dedicated to producing innovative products backed by proven results, Mary Kay® products garnered more than 40 awards in 2018 and already 22 in 2019. Among the products distinguished by the Beauty industry and consumers, Mary Kay TimeWise Miracle® 3D set, TimeWise Repair® Lifting Bio-Cellulose Mask, TimeWise® Vitamin C Activating Squares™, and Oil-Free Eye Makeup Remover, were the most rewarded.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through the Mary Kay Foundation℠, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
About Reputation Institute
Reputation Institute helps leaders at the world’s largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis. Past and present clients have included Whirlpool, Barnes & Noble,The Estée Lauder Companies, JP Morgan Chase & Co., LEGO, P&G, Cisco, and Telefonica, among many others.
About Seldia
Seldia recognizes the outstanding achievements of organizations that demonstrate excellence in empowerment, entrepreneurship and a commitment to producing best-in-the-industry products. Representing 28 national direct selling associations and 20 member-companies throughout Europe, Seldia’s mission is to promote the interest of national direct selling associations and direct selling companies in the European footprint. “Best Company of the Year” recognizes the corporate member that best raises awareness of the direct selling method of distribution, promotes the method’s socio-economic benefits and demonstrates a strong commitment to supporting the mission of Seldia.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190710005268/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom